Private Equity Portfolio COOs face increasing pressure to unlock value from GenAI, yet the reality is sobering: only 5% of portfolio companies successfully scale these initiatives beyond the pilot stage, unable to demonstrate short-term value, and not able to turn GenAI strategy into execution.
To operationalize GenAI at scale, COOs must embrace a pragmatic, results-driven approach that integrates GenAI into the fabric of core operations. These cannot be one-off initiatives, justified by ambitious run-rate ROI promises. Change at scale requires a relentless focus aimed at improving the “ways of working”.
With over $1.5 billion in EBITDA improvements across 60+ PE engagements, SSA & Co. has a proven track record of turning technology ambition into measurable business outcomes. Our GenAI playbook is designed to move with pace and deliver within holding periods.
